Development of antibodies to porcine calcitonin during treatment of Paget's disease of bone
Dube, W.J.; Goldsmith, R.S.; Arnaud, S.B.; Arnaud, C.D.
Mayo Clinic Proceedings 48(1): 43-46
1973
ISSN/ISBN: 0025-6196 PMID: 4734250 Document Number: 60343
Document emailed within 1 workday
Related Documents
Tarquini, B.; Ciapini, A.; Benvenuti, M.; Moretti, R.; Cherici, R.; Comparini, T.; Neri, B. 1980: Chronopharmacological effect of porcine calcitonin in Paget's disease of the bone La Clinica Terapeutica 94(6): 659-670Renier, J.C.; Boasson, M.; Jallet, P.; Bernat, M. 1973: Short term treatment of Paget's disease with porcine calcitonin Revue du Rhumatisme et des Maladies Osteo-Articulaires 40(10): 557-563
Manderlier, T.; Fuss, M.; Brauman, J.; Orloff, S.; Bergans, A.; Corvilain, J. 1976: Treatment of Paget's disease of bone with salmon calcitonin Acta Clinica Belgica 31(6): 329-338
Courvoisier, B.; de Barros, Q.; Jacot, C.; Zender, R. 1970: Acute effect of porcine calcitonin in persons without osteopathy and patients with Paget's disease Schweizerische Medizinische Wochenschrift 100(1): 26-32
Luboshitzky, R.; Bar-Shalom, R. 1995: Calcitonin nasal spray for Paget's disease of the bone Harefuah 128(6): 358-362; 399
Pembrook, R.C.; Chung, C.H.; Carvallo, A.P. 1975: Effects of mithramycin and calcitonin in cardiovascular complications of Paget's disease of bone Connecticut Medicine 39(4): 209-214
Epstein, S.; Owen, G. 1977: Paget's disease of bone (osteitis deformans) treated with human synthetic calcitonin South African Medical Journal 51(5): 133-137
Ghiringhelli, G.; Fogel, M.; Varela de Rodríguez, J.; Casco, C.; Mautelén, C.; Nusimovich, B. 1982: Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate Medicina 42(1): 16-20
Miravet, L.; Kuntz, D. 1989: Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate Revue du Rhumatisme et des Maladies Osteo-Articulaires 56(4): 287-292
Detilleux, M.; Guillausseau, P.J.; Caquet, R.; Reynaud, M.; Metzger, J.; Askienazy, S.; Laroche, C. 1977: Paget's disease with obstructive communicating hydrocephalus and dementia. Favorable outcome under the treatment with calcitonin Annales de Medecine Interne 128(8-9): 667-672
Kalmakoff, J.; Maskill, W.J.; Thongkrajai, P.; Palmer, D.G. 1981: Antibodies against double-stranded RNA in patients with rheumatoid arthritis, osteoarthrosis and Paget's disease of bone Australian and New Zealand Journal of Medicine 11(2): 173-178
Louyot, P.; Pourel, J. 1974: Paget's disease and calcitonin. Personal experience Acta Orthopaedica Belgica 40(4): 538-545
Mimura, K. 1985: Treatment of Paget's disease of bone Nihon Seikeigeka Gakkai Zasshi 59(8): 751-761
Bockman, R.S.; Weinerman, S.A. 1993: Medical treatment for Paget's disease of bone Instructional Course Lectures 42: 425-433
Fromm, G.A.; Plantalech, L.; Casco, C.; González, D.; Mautalen, C.A. 1984: Treatment of Paget's bone disease with a bisphosphonate Medicina 44(3): 245-251
Wilczek, H.; Stĕpán, J. 1993: Paget's disease of bone and treatment with pamidronate Vnitrni Lekarstvi 39(7): 690-698
Wenz, W.; Basler, L. 1985: Significance of x-ray diagnosis in the control of calcitonin therapy of Paget's disease: case report Der Radiologe 25(12): 594-596
Dolgitser, M.; Stern, L.; Katz, L.M.; Doyle, J.J.; Omar, M.; Seton, M.; Kahler, K.H. 2007: Bisphosphonate use in the treatment of Paget's disease of the bone: analysis of claims in a large database Managed Care Interface 20(2): 33-40
Evans, R.A.; Dunstan, C.R.; Hills, E.; Wong, S.Y. 1983: Pathologic fracture due to severe osteomalacia following low-dose diphosphonate treatment of Paget's disease of bone Australian and New Zealand Journal of Medicine 13(3): 277-279
De Vries, H.R.; Bijvoet, O.L. 1974: Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP) Netherlands Journal of Medicine 17(6): 281-298